<(Background)under bar>: Secondary hyperparathyroidism and its effects on b
one and viscera are among the most important complications of end-stage ren
al disease. Despite its ubiquity, little is known about the treated natural
history of the disorder. <(Methods)under bar>: We assembled a cohort of 31
0 patients with endstage renal disease on hemodialysis who were participant
s in one of four clinical trials of the phosphate binder sevelamer. Baselin
e parathyroid hormone levels were collected, and the relation between dialy
sis vintage and other clinical variables with parathyroid hormone were desc
ribed. <(Results)under bar>: There was a direct relation between dialysis v
intage and the severity of hyperparathyroidism. Other variables that were s
ignificantly associated with PTH on univariate analysis included age, Afric
an American race, Kt/V, and the serum concentrations of calcium, phosphate,
and bicarbonate. Multivariable linear regression analysis yielded three si
gnificant predictors of PTH: calcium, phosphorus, and vintage (5.8% (4.0 -
7.5%) expected increase in PTH per year of vintage). The model R-2 was 0.22
. <(Conclusion)under bar>: Dialysis vintage is a key determinant of the sev
erity of secondary hyperparathyroidism. Vintage and certain laboratory vari
ables should be considered in the evaluation of therapies aimed at modifyin
g the treated natural history of this disorder.